Vistagen therapeutics inc - expands ph94b clinical development to include adjustment disorder related to covid-19

Vistagen therapeutics inc - expands ph94b clinical development to include adjustment disorder related to covid-19.vistagen therapeutics - to submit proposed protocol for a phase 2 study of ph94b fda through fda’s new coronavirus treatment acceleration program.vistagen therapeutics inc - currently preparing for phase 3 development of ph94b for treatment of social anxiety disorder.
VTGN Ratings Summary
VTGN Quant Ranking